Astellas is committed to providing timely and accurate information about our business, science and products. This section offers local resources for investors, journalists and media professionals. Global news and resources can be viewed here. If you are not an investor or journalist, click here.
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
The National Kidney Foundation (NKF) announced today, during National Donate Life Month, that Astellas Pharma US, Inc. was named the first-ever National Presenting Sponsor for the Kidney Walk....
The American Urological Association (AUA) and Astellas US LLC, a U.S. affiliate of Tokyo-based Astellas Pharma Inc., have announced a $3 million commitment to the Urology Care Foundation and to...
-- If isavuconazole is approved for invasive mucormycosis, QIDP status provides a five-year extension of market exclusivity -- NORTHBROOK, Ill., Feb. 27, 2014 /PRNewswire/ -- Astellas Pharma...
ASCO GU Names Abstract Among Four to Be Highlighted During 2014 Meeting SAN FRANCISCO, CA AND NORTHBROOK, Ill. – December 19, 2013 -- Medivation Inc. (NASDAQ: MDVN) and Astellas Pharma Global...
NORTHBROOK, Ill. and SAN DIEGO, Dec. 10, 2013 /PRNewswire/ -- Astellas Pharma Global Development, Inc., a subsidiary of Tokyo-based Astellas Pharma Inc. (Tokyo: 4503), and Vical Incorporated...
San Francisco, CA and Northbrook, IL – December 4, 2013 – Medivation, Inc. (Nasdaq: MDVN) and Astellas Pharma US, Inc., a U.S. subsidiary of Tokyo-based Astellas Pharma Inc. (Tokyo: 4503)...
NORTHBROOK, Ill., Dec. 3, 2013 /PRNewswire/ -- Astellas Pharma US, Inc., a subsidiary of Astellas Pharma Inc. based in Tokyo, Japan, announced today that the U.S. Food and Drug Administration...
Win recognizes outstanding financial and R&D performance as Astellas brings an array of new medicines to market for patients in need NORTHBROOK, Ill., Nov. 22, 2013 /PRNewswire/ -- Astellas US...
Read more about Astellas named 'Company of the Year' at international SCRIP Awards 2013
San Francisco, CA and Northbrook, IL – November 12, 2013 – Astellas Pharma US, Inc., a U.S. subsidiary of Tokyo-based Astellas Pharma Inc. (Tokyo: 4503), and Medivation, Inc. (Nasdaq: MDVN)...
NORTHBROOK, Ill., Oct. 30, 2013 /PRNewswire/ -- Astellas US LLC ("Astellas"), a subsidiary of Astellas Pharma Inc. based in Tokyo, Japan, welcomes Jeffrey Winton as senior vice president, chief...
Read more about Astellas US Appoints Senior Vice President, Chief Communications Officer
Astellas Pharma Global Development, Inc. (“APGD”), a subsidiary of Astellas Pharma Inc. based in Tokyo, Japan, announces today the promotion of Mark Weinberg, M.D., MBA to Vice President of...
Read more about Astellas Announces Growth of Global Development Team
NORTHBROOK, Ill., Sept. 27, 2013 /PRNewswire/ -- Employees from Astellas Pharma US, Inc. (Astellas Pharma US), the U.S. subsidiary of Tokyo-based Astellas Pharma Inc., will step away from their...
Read more about Astellas Employees to 'Change Tomorrow' through Annual Day of Service
As men live longer with disease, survey findings suggest patients and caregivers need increased opportunities for open dialogue and more comprehensive support NORTHBROOK, Ill. and SAN FRANCISCO...
Tournament fans can also "take their shot at being a news anchor" at the Astellas Women's experience ATLANTA and NORTHBROOK, Ill., Sept. 17, 2013 /PRNewswire/ -- The PGA TOUR and Astellas Pharma...
Read more about Astellas to Host Executive Women's Day at 2013 TOUR Championship by Coca-Cola
NORTHBROOK, Ill., Aug. 22, 2013 /PRNewswire/ -- Astellas Pharma US, Inc. ("Astellas"), a U.S. subsidiary of Tokyo-based Astellas Pharma Inc. (Tokyo: 4503), announced today that ASTAGRAF XLTM...
NORTHBROOK, Ill., July 31, 2013 /PRNewswire/ -- Astellas Pharma Global Development, Inc. ("APGD"), a subsidiary of Astellas Pharma Inc. based in Tokyo, Japan, welcomes Claire Thom, Pharm.D.,...
Read more about Astellas Appoints New Senior Vice President of Global Oncology Development
New initiative highlights the physical and emotional burden of overactive bladder through a unique mix of educational programs NORTHBROOK, Ill., July 24, 2013 /PRNewswire/ -- As part of its...
Read more about Astellas Helps Patients Identify with their "OAB Reality"
NORTHBROOK, Ill., July 19, 2013 /PRNewswire/ -- Astellas Pharma US, Inc. ("Astellas"), a U.S. subsidiary of Tokyo-based Astellas Pharma Inc. (Tokyo: 4503), announced today that the U.S. Food and...
NORTHBROOK, Ill., July 8, 2013 /PRNewswire/ -- On July 10, 2013, The Cove School in Northbrook, which serves children with learning disabilities from 60 school districts throughout the Chicagoland...
BOTHELL, Wash., & SANTA MONICA, Calif., June 27, 2013 – Seattle Genetics, Inc. (Nasdaq: SGEN) and Agensys, Inc., an affiliate of Tokyo-based Astellas Pharma Inc. (Tokyo:4503), today announced...
Event is part of the PGA TOUR's Women's Initiative, sponsored by Astellas, and is expected to attract more than 200 female leaders PITTSBURGH, Pa, and NORTHBROOK, Ill., June 25, 2013 /PRNewswire/...
On-course Women's Pavilion also at tournament as part of the PGA TOUR's Women's Initiative, sponsored by Astellas BETHESDA, Md., and NORTHBROOK, Ill., June 24, 2013 /PRNewswire/ -- The PGA TOUR...
NORTHBROOK, Ill., June 24, 2013 /PRNewswire/ -- Astellas Pharma US, Inc. ("Astellas"), a U.S. subsidiary of Tokyo-based Astellas Pharma Inc. (Tokyo: 4503), announced that the U.S. Food and Drug...
NORTHBROOK, IL – June 20, 2013 – Astellas US LLC (“Astellas”) was named one of the 100 top organizations honored in IDG's Computerworld 2013 Best Places to Work in IT. Astellas was the...
NORTHBROOK, Ill., June 5, 2013 /PRNewswire/ -- Astellas Pharma US, Inc. ("Astellas"), a subsidiary of Tokyo-based Astellas Pharma Inc. (Tokyo: 4503), announced today that the company has entered...
Follow U.S. news
